Given that the loss of or reduced ER-α expression is a primary mechanism for tamoxifen resistance, we next tested whether δEF1 overexpression in breast cancer cells would confer resistance to tamoxifen-mediated cell growth inhibition and cell death. This evidence concerns the gene ESR1 and breast carcinoma.